Literature DB >> 10234009

Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.

W Jin1, S Brown, J P Roche, C Hsieh, J P Celver, A Kovoor, C Chavkin, K Mackie.   

Abstract

Desensitization of cannabinoid receptor signaling by a G-protein coupled receptor kinase (GRK) was examined using the Xenopus oocyte expression system. Application of a CB1 agonist, WIN 55,212-2, evoked a concentration-dependent increase in K+ conductance (Kir3) in oocytes coexpressing rat CB1 with the G-protein-gated, inwardly rectifying K+ channels Kir3.1 and Kir3.4. Desensitization was slight during continuous agonist application in the absence of GRK and arrestin. However, coexpression of GRK3 and beta-arrestin 2 (beta-arr2) caused profound homologous CB1 receptor desensitization, supporting the hypothesis that GRK3 and beta-arr2 effectively produce CB1 receptor desensitization. To identify the regions of the CB1 receptor responsible for GRK3- and beta-arr2-mediated desensitization, we constructed several CB1 receptor mutants. Truncation of the C-terminal tail of CB1 receptor at residue 418 (Delta418) almost completely abolished desensitization but did not affect agonist activation of Kir3. In contrast, truncation at residues 439 and 460 did not significantly affect GRK3- and beta-arr2-dependent desensitization. A deletion mutant (Delta418-439) did not desensitize, indicating that residues within this region are important for GRK3- and beta-arr2-mediated desensitization. Phosphorylation in this region was likely involved in desensitization, because mutation of either of two putative phosphorylation sites (S426A or S430A) significantly attenuated desensitization. CB1 receptors rapidly internalize after activation by agonist. Phosphorylation of S426 or S430 was not necessary for internalization, because the S426A/S430A CB1 mutant internalized when stably expressed in AtT20 cells. These studies establish that CB1 desensitization can be regulated by a GRK and that different receptor domains are involved in GRK- and beta-arrestin-dependent desensitization and CB1 internalization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234009      PMCID: PMC6782730     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

1.  The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis.

Authors:  H G Dohlman; M Bouvier; J L Benovic; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

2.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

Review 3.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

Review 4.  Structure and mechanism of the G protein-coupled receptor kinases.

Authors:  J Inglese; N J Freedman; W J Koch; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

5.  Internalization and recycling of the CB1 cannabinoid receptor.

Authors:  C Hsieh; S Brown; C Derleth; K Mackie
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

6.  A second endogenous cannabinoid that modulates long-term potentiation.

Authors:  N Stella; P Schweitzer; D Piomelli
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

Review 7.  Neurobiology of marijuana abuse.

Authors:  M E Abood; B R Martin
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

8.  Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor.

Authors:  D E Garcia; S Brown; B Hille; K Mackie
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

9.  Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).

Authors:  A Kovoor; D J Henry; C Chavkin
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

10.  Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.

Authors:  G Pei; B L Kieffer; R J Lefkowitz; N J Freedman
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

View more
  97 in total

1.  Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.

Authors:  J Nie; D L Lewis
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.

Authors:  Erica J Melief; Mayumi Miyatake; Michael R Bruchas; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

3.  Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.

Authors:  George D Dalton; Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Authors:  Tricia H Smith; Laura J Sim-Selley; Dana E Selley
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Chem Inf Model       Date:  2019-12-10       Impact factor: 4.956

Review 6.  Molecular model of cannabis sensitivity in developing neuronal circuits.

Authors:  Erik Keimpema; Ken Mackie; Tibor Harkany
Journal:  Trends Pharmacol Sci       Date:  2011-07-13       Impact factor: 14.819

Review 7.  Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years.

Authors:  Alex Straiker; Ken Mackie
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

8.  Interaction of a fragment of the cannabinoid CB1 receptor C-terminus with arrestin-2.

Authors:  Kunal Bakshi; Richard W Mercier; Spiro Pavlopoulos
Journal:  FEBS Lett       Date:  2007-09-24       Impact factor: 4.124

9.  ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.

Authors:  Matthew F Lazenka; Dana E Selley; Laura J Sim-Selley
Journal:  Neuropharmacology       Date:  2013-09-30       Impact factor: 5.250

10.  Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.

Authors:  Jahan Marcu; Derek M Shore; Ankur Kapur; Megan Trznadel; Alexandros Makriyannis; Patricia H Reggio; Mary E Abood
Journal:  J Pharmacol Exp Ther       Date:  2013-02-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.